Effect of Polidocanol Endovenous Microfoam (PEM) Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers (VLUs)

Trial Profile

Effect of Polidocanol Endovenous Microfoam (PEM) Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers (VLUs)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 21 Sep 2017

At a glance

  • Drugs Polidocanol (Primary)
  • Indications Leg ulcer; Varicose veins
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Sep 2017 Planned End Date changed from 1 Apr 2019 to 12 Sep 2017.
    • 14 Sep 2017 Planned primary completion date changed from 1 Apr 2018 to 12 Sep 2017.
    • 14 Sep 2017 Planned initiation date changed from 1 Jan 2017 to 10 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top